Antibody Persistence and Safety through 6 Months after Heterologous Orally Aerosolised Ad5-nCoV in individuals primed with two-dose CoronaVac previously
bioRxiv (2022) - Comments
doi: 10.1101/2022.07.26.22278072 

Lairun Jin, Rong Tang, Shipo Wu, Xiling Guo, Lihua Hou, Xiaoqin Chen, Tao Zhu, Jinbo Gou, Haitao Huang, Jin Zhong, Hongxing Pan, Lunbiao Cui, Yin Chen, Xin Xia, Jialu Feng, Xue Wang, Qi Zhao, XiaoYu Xu, Zhuopei Li, Xiaoyin Zhang